36 results on '"Torres-Aguilar H"'
Search Results
2. Liver damage in bleomycin-induced pulmonary fibrosis in mice
- Author
-
Vásquez-Garzón, V. R., Ramírez-Cosmes, A., Reyes-Jiménez, E., Carrasco-Torres, G., Hernández-García, S., Aguilar-Ruiz, S. R., Torres-Aguilar, H., Alpuche, J., Pérez-Campos Mayoral, L., Pina-Canseco, S., Arellanes-Robledo, J., Villa-Treviño, S., and Baltiérrez-Hoyos, R.
- Published
- 2019
- Full Text
- View/download PDF
3. Human plasmacytoid dendritic cells express the functional purinergic halo (CD39/CD73)
- Author
-
Sosa-Luis, S. A., primary, Ríos-Ríos, W. J., additional, Almaraz-Arreortua, A., additional, Romero-Tlalolini, M. A., additional, Aguilar-Ruiz, S. R., additional, Valle-Ríos, R., additional, Sánchez-Torres, C., additional, and Torres-Aguilar, H., additional
- Published
- 2023
- Full Text
- View/download PDF
4. Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4+ T cell response to [beta]2GPI.
- Author
-
Torres-Aguilar H, Blank M, Kivity S, Misgav M, Luboshitz J, Pierangeli SS, and Shoenfeld Y
- Published
- 2012
- Full Text
- View/download PDF
5. Pesticide Exposure in the Cultivation of Carica papaya L. and Capsicum annuum L. in Rural Areas of Oaxaca, Mexico.
- Author
-
Bernardino-Hernández HU, Gallardo-García Y, Vargas-Valencia G, Zapién-Martínez A, Sánchez-Cruz G, Reyes-Velasco L, Cueva-Villanueva JÁ, Hernández-García E, Vargas-Arzola J, and Torres-Aguilar H
- Subjects
- Mexico, Humans, Adult, Middle Aged, Female, Male, Rural Population, Young Adult, Agriculture, Health Knowledge, Attitudes, Practice, Environmental Exposure, Occupational Exposure, Adolescent, Aged, Capsicum, Carica, Pesticides toxicity
- Abstract
This study focuses on describing the diversity of pesticides, the knowledge and behaviors of their use, and the acute poisoning symptoms (APS) derived from their exposure from two agricultural production systems (papaya- Carica papaya L.- and chili- Capsicum annuum L.-) in Oaxaca, Mexico. Through surveys, sociodemographic information, characteristics of the production system, knowledge and behaviors in the handling of pesticides, and APS perceived by users were captured. Papaya producers are younger, have fewer years of activity, and have larger agricultural areas than chili producers. Insect attacks and diseases are an essential factor for the application of pesticides. Thirty-one active ingredients (Ais) were identified in papaya and thirty-seven in chili, predominantly insecticides and fungicides of toxicological category IV. Approximately 50% of users apply mixtures of different Ais, have little knowledge and inappropriate behavior in their handling, and report up to five acute pesticide poisoning symptoms, mainly burning and irritation of the skin, burning eyes, itchy skin, runny nose, headache, and watery eyes. The production of papaya and chili are relevant activities for generating economic income, but they risk the producer's and their family's health. Both systems are a potential scenario for the manifestation of diseases due to exposure to pesticides in the medium and long term.
- Published
- 2024
- Full Text
- View/download PDF
6. IFN-γ-Preconditioned Human Gingival-Derived Mesenchymal Stromal Cells Inhibit Plasmacytoid Dendritic Cells via Adenosine.
- Author
-
Ríos-Ríos WJ, Sosa-Luis SA, Almaraz-Arreortua A, Vargas-Benitez P, Bernardino-Hernández HU, Vargas-Arzola J, Hernández-Osorio LA, Romero-Tlalolini MLÁ, Aguilar-Ruiz SR, and Torres-Aguilar H
- Subjects
- Humans, Cells, Cultured, Apyrase metabolism, GPI-Linked Proteins, Mesenchymal Stem Cells metabolism, Mesenchymal Stem Cells immunology, Mesenchymal Stem Cells cytology, Dendritic Cells immunology, Dendritic Cells metabolism, Adenosine metabolism, Interferon-gamma metabolism, Gingiva cytology, 5'-Nucleotidase metabolism
- Abstract
Plasmacytoid dendritic cells (pDCs) are vital players in antiviral immune responses because of their high levels of IFN-α secretion. However, this attribute has also implicated them as critical factors behind the immunopathogenesis of inflammatory diseases, and no currently available therapy can efficiently inhibit pDCs' aberrant activation. Mesenchymal stromal cells (MSCs) possess stromal immunomodulatory functionality, regulating immune cell activation through several mechanisms, including the adenosinergic (CD39/CD73/adenosine) pathway. The IFN-γ preconditioning of bone marrow MSCs improves their inhibitory properties for therapy applications; however, isolating human gingival tissue-derived MSCs (hGMSCs) is more accessible. These cells have shown better immunomodulatory effects, yet the outcome of IFN-γ preconditioning and its impact on the adenosinergic pathway has not been evaluated. This study first validated the immunoregulatory properties of primary-cultured hGMSCs, and the results showed that IFN-γ preconditioning strengthens CD39/CD73 coexpression, adenosine production, and the regulatory properties of hGMSC, which were confirmed by describing for the first time their ability to reduce pDC activation and their IFN-α secretion and to increase the frequency of CD73+ pDC. In addition, when CD73's enzymatic activity was neutralized in hGMSCs, adenosine production and the IFN-γ preconditioning effect were restrained. This evidence might be applied to design hGMSCs- and adenosine-based immunotherapeutic strategies for treating inflammatory disorders that are associated with pDC overactivation.
- Published
- 2024
- Full Text
- View/download PDF
7. Detection of Asymptomatic Sickle Cell Hemoglobin Carriers and Fetal Hemoglobin Regulating Genetic Variants in African Descendants from Oaxaca, Mexico.
- Author
-
Romero-Tlalolini MLÁ, Aguilar-Ruiz SR, Baltiérrez-Hoyos R, Vargas-Arzola J, Hernández-Osorio LA, Vásquez-Garzón VR, Bernardino-Hernández HU, and Torres-Aguilar H
- Abstract
Sickle cell anemia has been classified as a noninfectious neglected tropical disease and, although not exclusively, affects African descendants more frequently. This study aimed to detect asymptomatic sickle cell hemoglobin carriers (HbAS) in marginalized and vulnerable populations during a public health screening in African descendants from Oaxaca, Mexico, and to validate an amplification refractory mutation system (ARMS)-PCR methodology to detect fetal-hemoglobin (HbF)-regulating genetic variants in BCL11A toward affordable routine association of single nucleotide variants (SNVs) with HbF concentrations. To this aim, hemoglobin variants were detected by acidic citrate agar and alkaline cellulose acetate electrophoreses. SNVs in the hemoglobin subunit beta gene (HBB) were identified by the β -globin mutation detection assay ( β -GMDA) and ARMS-PCR, respectively, and validated by Sanger sequencing. The association between genotypes and HbF concentrations was evaluated using Spearman's correlation coefficient. The results obtained during a directed screening in 140 self-identified African descendants revealed 42 HbS-carriers (30%), of which 39 showed normal total hemoglobin concentrations (92.8%), only 3 presented anemia (7.2%), and 9 showed quantifiable HbF concentration (21.4%). As validated by Sanger sequencing, the designed ARMS-PCR efficiently detected homozygous and heterozygous variants in BCL11A. In a cohort of 42 heterozygous (HbAS) and 27 healthy (HbAA) individuals from the same population, only one SNV (rs766432) showed statistically significant association with increasing HbF concentration, and two new unrelated homozygous silent variants were identified. This study reveals the need to raise coverage of HbS screening in vulnerable populations and shows a feasible low-cost ARMS-PCR methodology to determine the presence of SNVs in quantitative trait loci affecting HbF., Competing Interests: The authors declare that there are no conflicts of interest., (Copyright © 2024 María De Los Ángeles Romero-Tlalolini et al.)
- Published
- 2024
- Full Text
- View/download PDF
8. Echeveria Pallida: Inhibiting Adhesion of Fibroblasts From Pterygium and Neutrophil Extracellular Traps Production.
- Author
-
de Jesús Rios-Rios W, Pérez-Vásquez A, Manzanero-Medina GI, Sosa-Luis SA, and Torres-Aguilar H
- Subjects
- Neutrophils, Cell Adhesion, Humans, Cells, Cultured, Fibroblasts drug effects, Pterygium, Extracellular Traps, Crassulaceae chemistry, Plant Extracts pharmacology
- Abstract
Context: Pterygium, meaty eyes, is a disease that produces a triangular, conjunctival-epithelial, neovascularized overgrowth covering the cornea, which can cause vision loss. Histological characterization of Pterygium reveals the presence of proliferating fibroblasts (FBs) that remodel the extracellular matrix, with infiltration of immune cells, causing chronic inflammation. The fresh juice of Echeveria pallida E. Walther (Crassulaceae), mechanically extracted from the leaves, can be used to lubricate the eyes and remove Pterygium, even in advanced, degenerative ocular disease., Objective: This study aimed to explore the healing mechanisms of an ethanolic extract of E. pallida on pterygium-derived FBs, lymphocytes, and neutrophils., Design: The research team designed an in-vitro study. Primary cultures of FBs were obtained from fresh, surgical pterygium tissues, and neutrophils and mononuclear cells were purified from the peripheral blood of healthy donors., Intervention: An ethanolic extract of E. pallida was evaluated at 30, 50, 80, 100, 200, and 300 µg/mL-the intervention groups-for viability and proliferation of FBs and lymphocytes. The study included a negative control with no extract, and a positive control, Mitomycin C (MMC), used as a FB proliferation inhibitor and anti-inflammatory. Because some reports have suggested that DMSO at low concentrations can stimulate or inhibit lymphocyte proliferation depending on the cell type, the study also included a DMSO control., Outcome Measures: The measures included an analysis of E. pallida's effects on the proliferation and viability of FBs, the proliferation of human lymphocytes, and human neutrophil extracellular traps (NETs) production. NETs were induced using biochemical and microbiological stimuli-phorbol myristate acetate (PMA), hypochlorous acid (HOCl), Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans-through fluorescence microscopy., Results: The ethanolic extract didn't affect the viability or proliferation of pterygium-derived FBs and human blood lymphocytes, but it showed significant inhibitory activity, from 100 µg/mL, on FB adhesion and the production of NETs., Conclusion: The study found scientific evidence that supports the effects of an extract of the medicinal plant E. pallida in inhibiting the adhesion of FBs derived from human pterygium and NET production.
- Published
- 2023
9. Zingiber officinale -Derived Extracellular Vesicles Attenuate Bleomycin-Induced Pulmonary Fibrosis Trough Antioxidant, Anti-Inflammatory and Protease Activity in a Mouse Model.
- Author
-
Ramírez-Hernández AA, Reyes-Jiménez E, Velázquez-Enríquez JM, Santos-Álvarez JC, Soto-Guzmán A, Castro-Sánchez L, Tapia-Pastrana G, Torres-Aguilar H, Vásquez-Garzón VR, and Baltiérrez-Hoyos R
- Subjects
- Mice, Animals, Bleomycin therapeutic use, Antioxidants pharmacology, Antioxidants therapeutic use, Disease Models, Animal, Proteomics, Anti-Inflammatory Agents pharmacology, Peptide Hydrolases, Zingiber officinale, Idiopathic Pulmonary Fibrosis metabolism, Extracellular Vesicles metabolism
- Abstract
Idiopathic pulmonary fibrosis (IPF) is the most frequent and severe idiopathic interstitial pneumonia. It is a chronic and progressive disease with a poor prognosis and is a major cause of morbidity and mortality. This disease has no cure; therefore, there is a clinical need to search for alternative treatments with greater efficacy. In this study, we aimed to evaluate the effect of extracellular vesicles (EVs) from Zingiber officinale (EVZO) in a murine model of bleomycin (BLM)-induced IPF administered through an osmotic minipump. EVZO had an average size of 373 nm and a spherical morphology, as identified by scanning electron microscopy. Label-free proteomic analysis of EVZOs was performed by liquid chromatography coupled to mass spectrometry, and 20 proteins were identified. In addition, we demonstrated the protease activity of EVZO by gelatin-degrading zymography assay and the superoxide dismutase (SOD) activity of EVZO by an enzymatic assay. In the BLM-induced IPF mouse model, nasal administration of 50 μg of EVZO induced recovery of alveolar space size and decreased cellular infiltrate, collagen deposition, and expression of α-SMA-positive cells. Additionally, EVZO inhibited inflammatory markers such as iNOS and COX-2, lipid peroxidation, and apoptotic cells. These results show that EVZO may represent a novel natural delivery mechanism to treat IPF.
- Published
- 2023
- Full Text
- View/download PDF
10. Quantitative Proteomics for the Identification of Differentially Expressed Proteins in the Extracellular Vesicles of Cervical Cancer Cells.
- Author
-
Acevedo-Sánchez V, Martínez-Ruiz RS, Aguilar-Ruíz SR, Torres-Aguilar H, Chávez-Olmos P, Garrido E, Baltiérrez-Hoyos R, and Romero-Tlalolini MLA
- Subjects
- Female, Humans, Chromatography, Liquid, HeLa Cells, Proteomics, Tandem Mass Spectrometry, Proteins metabolism, Tumor Microenvironment, Uterine Cervical Neoplasms metabolism, Papillomavirus Infections metabolism, Extracellular Vesicles metabolism
- Abstract
The extracellular vesicles (EVs) in a tumoral microenvironment can exert different functions by transferring their content, which has been poorly described in cervical cancer. Here, we tried to clarify the proteomic content of these EVs, comparing those derived from cancerous HPV (+) keratinocytes (HeLa) versus those derived from normal HPV (-) keratinocytes (HaCaT). We performed a quantitative proteomic analysis, using LC-MS/MS, of the EVs from HeLa and HaCaT cell lines. The up- and downregulated proteins in the EVs from the HeLa cell line were established, along with the cellular component, molecular function, biological processes, and signaling pathways in which they participate. The biological processes with the highest number of upregulated proteins are cell adhesion, proteolysis, lipid metabolic process, and immune system processes. Interestingly, three of the top five signaling pathways with more up- and downregulated proteins are part of the immune response. Due to their content, we can infer that EVs can have a significant role in migration, invasion, metastasis, and the activation or suppression of immune system cells in cancer.
- Published
- 2023
- Full Text
- View/download PDF
11. LL-37 Triggers Antimicrobial Activity in Human Platelets.
- Author
-
Sánchez-Peña FJ, Romero-Tlalolini MLÁ, Torres-Aguilar H, Cruz-Hernández DS, Baltiérrez-Hoyos R, Sánchez-Aparicio SR, Aquino-Domínguez AS, and Aguilar-Ruiz SR
- Subjects
- Humans, Escherichia coli metabolism, Blood Platelets metabolism, Carrier Proteins, Cathelicidins pharmacology, Cathelicidins metabolism, Anti-Infective Agents
- Abstract
Platelets play a crucial role in hemostasis and the immune response, mainly by recognizing signals associated with vascular damage. However, it has recently been discovered that the antimicrobial peptide LL-37 activates platelets in functions related to thrombus formation and inflammation. Therefore, this work aims to evaluate the effect of LL-37 on the activation of antimicrobial functions of human platelets. Our results show that platelets treated with LL-37 increase the surface expression of receptors (Toll-like receptors (TLRs) 2 and -4, CD32, CD206, Dectin-1, CD35, LOX-1, CD41, CD62P, and αIIbβ3 integrins) for the recognition of microorganisms, and molecules related to antigen presentation to T lymphocytes (CD80, CD86, and HLA-ABC) secrete the antimicrobial molecules: bactericidal/permeability-increasing protein (BPI), azurocidin, human neutrophil peptide (HNP) -1, and myeloperoxidase. They also translate azurocidin, and have enhanced binding to Escherichia coli, Staphylococcus aureus, and Candida albicans. Furthermore, the supernatant of LL-37-treated platelets can inhibit E. coli growth, or platelets can employ their LL-37 to inhibit microbial growth. In conclusion, these findings demonstrate that LL-37 participates in the antimicrobial function of human platelets.
- Published
- 2023
- Full Text
- View/download PDF
12. Leukocyte surface expression of the endoplasmic reticulum chaperone GRP78 is increased in severe COVID-19.
- Author
-
Angeles-Floriano T, Sanjuan-Méndez A, Rivera-Torruco G, Parra-Ortega I, Lopez-Martinez B, Martinez-Castro J, Marin-Santiago S, Alcántara-Hernández C, Martínez-Martínez A, Márquez-González H, Klünder-Klünder M, Olivar-López V, Zaragoza-Ojeda M, Arenas-Huertero F, Torres-Aguilar H, Medina-Contreras O, Zlotnik A, and Valle-Rios R
- Subjects
- Humans, Heat-Shock Proteins genetics, Heat-Shock Proteins metabolism, Leukocytes, Mononuclear metabolism, Molecular Chaperones genetics, Endoplasmic Reticulum metabolism, Endoplasmic Reticulum Stress, Endoplasmic Reticulum Chaperone BiP, COVID-19 metabolism
- Abstract
Hyperinflammation present in individuals with severe COVID-19 has been associated with an exacerbated cytokine production and hyperactivated immune cells. Endoplasmic reticulum stress leading to the unfolded protein response has been recently reported as an active player in inducing inflammatory responses. Once unfolded protein response is activated, GRP78, an endoplasmic reticulum-resident chaperone, is translocated to the cell surface (sGRP78), where it is considered a cell stress marker; however, its presence has not been evaluated in immune cells during disease. Here we assessed the presence of sGRP78 on different cell subsets in blood samples from severe or convalescent COVID-19 patients. The frequency of CD45+sGRP78+ cells was higher in patients with the disease compared to convalescent patients. The latter showed similar frequencies to healthy controls. In patients with COVID-19, the lymphoid compartment showed the highest presence of sGRP78+ cells versus the myeloid compartment. CCL2, TNF-α, C-reactive protein, and international normalized ratio measurements showed a positive correlation with the frequency of CD45+sGRP78+ cells. Finally, gene expression microarray data showed that activated T and B cells increased the expression of GRP78, and peripheral blood mononuclear cells from healthy donors acquired sGRP78 upon activation with ionomycin and PMA. Thus, our data highlight the association of sGRP78 on immune cells in patients with severe COVID-19., (© The Author(s) 2023. Published by Oxford University Press on behalf of Society for Leukocyte Biology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
13. Evaluation of renal damage in a bleomycin-induced murine model of systemic sclerosis.
- Author
-
Pérez-Figueroa DC, Reyes-Jiménez E, Velázquez-Enríquez JM, Reyes-Avendaño I, González-García K, Villa-Treviño S, Torres-Aguilar H, Baltiérrez-Hoyos R, and Vásquez-Garzón VR
- Abstract
Objectives: Systemic sclerosis (SSc) is an autoimmune disease of unknown etiology with a high mortality rate. Renal crisis has been reported as one of the predictors of early mortality in these patients. The present study was performed to evaluate bleomycin-induced SSc using an osmotic minipump as a possible model for the analysis of renal damage in SSc., Materials and Methods: Male CD1 mice were implanted with osmotic minipumps loaded with saline or bleomycin and sacrificed at 6 and 14 days. Histopathological analysis was performed through hematoxylin and eosin (H&E) and Masson's trichrome staining. The expression of endothelin 1 (ET-1), inducible nitric oxide synthase (iNOS), transforming growth factor β (TGF-β), and 8-hydroxy-2-deoxyguanosine (8-OHdG) was also evaluated by immunohistochemistry., Results: The administration of bleomycin induced a decrease in the length of Bowman's space (3.6 μm, P <0.001); an increase in collagen deposition (14.6%, P <0.0001); and an increase in the expression of ET-1 (7.5%, P <0.0001), iNOS (10.8%, P <0.0001), 8-OHdG (161 nuclei, P <0.0001), and TGF-β (2.4% µm, P <0.0001) on Day 6. On Day 14, a decrease in the length of Bowman's space (2.6 μm, P <0.0001); increased collagen deposition (13.4%, P <0.0001); and increased expression of ET-1 (2.7%, P <0.001), iNOS (10.1%, P <0.0001), 8-OHdG (133 nuclei, P <0.001), and TGF-β (0.6%, P <0.0001) were also observed., Conclusion: Systemic administration of bleomycin via an osmotic minipump produces histopathological changes in the kidneys, similar to kidney damage in SSc. Therefore, this model would allow the study of molecular alterations associated with SSc-related renal damage., Competing Interests: The authors declare that they have no conflicts of interest.
- Published
- 2023
- Full Text
- View/download PDF
14. Morphological and Compositional Analysis of Neutrophil Extracellular Traps Induced by Microbial and Chemical Stimuli.
- Author
-
Almaraz-Arreortua A, Sosa-Luis SA, Ríos-Ríos WJ, Romero-Tlalolini MLÁ, Aguilar-Ruiz SR, Baltiérrez-Hoyos R, and Torres Aguilar H
- Subjects
- Humans, Neutrophils, Pseudomonas aeruginosa, Microscopy, Fluorescence, DNA, Extracellular Traps
- Abstract
Neutrophils function as the first line of cellular defense in an innate immune response by employing diverse mechanisms, such as the formation of neutrophil extracellular traps (NETs). This study analyzes the morphological and compositional changes in NETs induced by microbial and chemical stimuli using standardized in vitro methodologies for NET induction and characterization with human cells. The procedures described here allow the analysis of NET morphology (lytic or non-lytic) and composition (DNA-protein structures and enzymatic activity), and the effect of soluble factors or cellular contact on such characteristics. Additionally, the techniques described here could be modified to evaluate the effect of exogenous soluble factors or cellular contact on NET composition. The applied techniques include the purification of polymorphonuclear cells from human peripheral blood using a double density gradient (1.079-1.098 g/mL), guaranteeing optimal purity and viability (≥ 95%) as demonstrated by Wright's staining, trypan blue exclusion, and flow cytometry, including FSC versus SSC analysis and 7AAD staining. NET formation is induced with microbial (Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans) and chemical (phorbol myristate acetate, HOCl) stimuli, and the NETs are characterized by DNA-DAPI staining, immunostaining for the antimicrobial peptide cathelicidin (LL37), and quantification of enzymatic activity (neutrophil elastase, cathepsin G, and myeloperoxidase). The images are acquired through fluorescence microscopy and analyzed with ImageJ.
- Published
- 2022
- Full Text
- View/download PDF
15. Human Platelets Contain, Translate, and Secrete Azurocidin; A Novel Effect on Hemostasis.
- Author
-
Aquino-Domínguez AS, Acevedo-Sánchez V, Cruz-Hernández DS, Sánchez-Aparicio SR, Romero-Tlalolini MLÁ, Baltiérrez-Hoyos R, Sánchez-Navarro LM, Torres-Aguilar H, Bustos-Arriaga J, and Aguilar-Ruiz SR
- Subjects
- Antimicrobial Cationic Peptides metabolism, Hemostasis, Humans, Thrombin metabolism, Blood Platelets metabolism, Blood Proteins metabolism
- Abstract
Platelets play a significant role in hemostasis and perform essential immune functions, evidenced by the extensive repertoire of antimicrobial molecules. Currently, there is no clear description of the presence of azurocidin in human platelets. Azurocidin is a 37 kDa cationic protein abundant in neutrophils, with microbicidal, opsonizing, and vascular permeability-inducing activity. Therefore, this work aimed to characterize the content, secretion, translation, and functions of azurocidin in platelets. Our results show the presence of azurocidin mRNA and protein in α-granules of platelet and megakaryoblasts, and stimulation with thrombin, ADP, and LPS leads to the secretion of free azurocidin as well as within extracellular vesicles. In addition, platelets can translate azurocidin in a basal or thrombin-induced manner. Finally, we found that the addition of low concentrations of azurocidin prevents platelet aggregation and activation. In conclusion, we demonstrate that platelets contain, secrete, and translate azurocidin, and this protein may have important implications for hemostasis.
- Published
- 2022
- Full Text
- View/download PDF
16. miRNAs Contained in Extracellular Vesicles Cargo Contribute to the Progression of Idiopathic Pulmonary Fibrosis: An In Vitro Aproach.
- Author
-
Santos-Álvarez JC, Velázquez-Enríquez JM, García-Carrillo R, Rodríguez-Beas C, Ramírez-Hernández AA, Reyes-Jiménez E, González-García K, López-Martínez A, Pérez-Campos Mayoral L, Aguilar-Ruiz SR, Romero-Tlalolini MLÁ, Torres-Aguilar H, Castro-Sánchez L, Arellanes-Robledo J, Vásquez-Garzón VR, and Baltiérrez-Hoyos R
- Subjects
- Cell Communication, Fibroblasts metabolism, Humans, Extracellular Vesicles metabolism, Idiopathic Pulmonary Fibrosis pathology, MicroRNAs genetics, MicroRNAs metabolism
- Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease. Lesions in the lung epithelium cause alterations in the microenvironment that promote fibroblast accumulation. Extracellular vesicles (EVs) transport proteins, lipids, and nucleic acids, such as microRNAs (miRNAs). The aim of this study was to characterize the differentially expressed miRNAs in the cargo of EVs obtained from the LL97 and LL29 fibroblast cell lines isolated from IPF lungs versus those derived from the CCD19 fibroblast cell line isolated from a healthy donors. We characterized EVs by ultracentrifugation, Western blotting, and dynamic light scattering. We identified miRNAs by small RNA-seq, a total of 1144 miRNAs, of which 1027 were known miRNAs; interestingly, 117 miRNAs were novel. Differential expression analysis showed that 77 miRNAs were upregulated and 68 were downregulated. In addition, pathway enrichment analyses from the Gene Ontology and Kyoto Encyclopedia of Genomes identified several miRNA target genes in the categories, cell proliferation, regulation of apoptosis, pathways in cancer, and proteoglycans in cancer. Our data reveal that miRNAs contained in EVs cargo could be helpful as biomarkers for fibrogenesis, diagnosis, and therapeutic intervention of IPF.
- Published
- 2022
- Full Text
- View/download PDF
17. Recent Advances in the Discovery and Function of Antimicrobial Molecules in Platelets.
- Author
-
Aquino-Domínguez AS, Romero-Tlalolini MLA, Torres-Aguilar H, and Aguilar-Ruiz SR
- Subjects
- Animals, Anti-Infective Agents chemistry, Anti-Infective Agents classification, Anti-Infective Agents immunology, Antimicrobial Cationic Peptides immunology, Antiparasitic Agents immunology, Antiviral Agents immunology, Blood Platelets immunology, Humans, Ribonucleases immunology, Anti-Infective Agents blood, Blood Platelets chemistry, Blood Platelets microbiology
- Abstract
The conventional function described for platelets is maintaining vascular integrity. Nevertheless, increasing evidence reveals that platelets can additionally play a crucial role in responding against microorganisms. Activated platelets release molecules with antimicrobial activity. This ability was first demonstrated in rabbit serum after coagulation and later in rabbit platelets stimulated with thrombin. Currently, multiple discoveries have allowed the identification and characterization of PMPs (platelet microbicidal proteins) and opened the way to identify kinocidins and CHDPs (cationic host defense peptides) in human platelets. These molecules are endowed with microbicidal activity through different mechanisms that broaden the platelet participation in normal and pathologic conditions. Therefore, this review aims to integrate the currently described platelet molecules with antimicrobial properties by summarizing the pathways towards their identification, characterization, and functional evaluation that have promoted new avenues for studying platelets based on kinocidins and CHDPs secretion.
- Published
- 2021
- Full Text
- View/download PDF
18. Extracellular Vesicles in Cervical Cancer and HPV Infection.
- Author
-
Acevedo-Sánchez V, Rodríguez-Hernández RM, Aguilar-Ruíz SR, Torres-Aguilar H, and Romero-Tlalolini MLA
- Abstract
Since their description, extracellular vesicles (EVs) have shown growing relevance in cancer progression. These cell structures contain and transfer molecules such as nucleic acids (including DNA and RNA), proteins, and lipids. Despite the rising information about EVs' relationship with cancer, there is still scarce evidence about their content and function in cervical cancer. Interestingly, the composition and purposes of some cellular molecules and the expression of oncogenic proteins packaged in EVs seem modified in HPV-infected cells; and, although only the E6 oncogenic protein has been detected in exosomes from HPV-positive cells, both E6/E7 oncogenes mRNA has been identified in EVs; however, their role still needs to be clarified. Given that EVs internalizing into adjacent or distant cells could modify their cellular behavior or promote cancer-associated events like apoptosis, proliferation, migration, or angiogenesis in receptor cells, their comprehensive study will reveal EV-associated mechanisms in cervical cancer. This review summarizes the current knowledge in composition and functions of cervical cancer and HPV Infection-derived EVs.
- Published
- 2021
- Full Text
- View/download PDF
19. Structural differences of neutrophil extracellular traps induced by biochemical and microbiologic stimuli under healthy and autoimmune milieus.
- Author
-
Sosa-Luis SA, Ríos-Ríos WJ, Gómez-Bustamante ÁE, Romero-Tlalolini MLÁ, Aguilar-Ruiz SR, Baltierez-Hoyos R, and Torres-Aguilar H
- Subjects
- Biomarkers analysis, Biomarkers metabolism, Candida albicans immunology, Case-Control Studies, Cathelicidins analysis, Cathelicidins metabolism, Cathepsin G analysis, Cathepsin G metabolism, Cells, Cultured, Extracellular Traps immunology, Healthy Volunteers, Humans, Hypochlorous Acid immunology, Leukocyte Elastase analysis, Leukocyte Elastase metabolism, Lupus Erythematosus, Systemic blood, Neutrophils immunology, Peroxidase analysis, Peroxidase metabolism, Primary Cell Culture, Pseudomonas aeruginosa immunology, Staphylococcus aureus immunology, Tetradecanoylphorbol Acetate immunology, Extracellular Traps metabolism, Lupus Erythematosus, Systemic immunology, Neutrophils metabolism
- Abstract
Neutrophil extracellular traps (NETs) are networks of decondensed chromatin loaded with antimicrobial peptides and enzymes produced against microorganisms or biochemical stimuli. Since their discovery, numerous studies made separately have revealed multiple triggers that induce similar NET morphologies allowing to classify them as lytic or non-lytic. However, the variability in NET composition depending on the inducer agent and the local milieu under similar conditions has been scarcely studied. In this work, a comparative study was conducted to evaluate structural and enzymatic divergences in NET composition induced by biochemical (phorbol myristate acetate [PMA] and hypochlorous acid [HOCl]) and microbiologic (Candida albicans, Staphylococcus aureus, and Pseudomonas aeruginosa) stimuli, along with the presence of plasma from healthy donors or patients with systemic lupus erythematosus (SLE). The results showed a differential composition of DNA and the antimicrobial peptide cathelicidin (LL37) and a variable enzymatic activity (neutrophil elastase, cathepsin G, myeloperoxidase) induced by the different stimuli despite showing morphologically similar NETs. Additionally, SLE plasma´s presence increased DNA and LL37 release during NET induction independently of the trigger stimulus but with no enzymatic activity differences. This work provides new evidence about NET composition variability depending on the inducer stimulus and the local milieu.
- Published
- 2021
- Full Text
- View/download PDF
20. Current advances in using tolerogenic dendritic cells as a therapeutic alternative in the treatment of type 1 diabetes.
- Author
-
Ríos-Ríos WJ, Sosa-Luis SA, and Torres-Aguilar H
- Abstract
Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction of insulin-producing β-cells of the pancreatic islets by autoreactive T cells, leading to high blood glucose levels and severe long-term complications. The typical treatment indicated in T1D is exogenous insulin administration, which controls glucose levels; however, it does not stop the autoimmune process. Various strategies have been implemented aimed at stopping β-cell destruction, such as cellular therapy. Dendritic cells (DCs) as an alternative in cellular therapy have gained great interest for autoimmune disease therapy due to their plasticity to acquire immunoregulatory properties both in vivo and in vitro , performing functions such as anti-inflammatory cytokine secretion and suppression of autoreactive lymphocytes, which are dependent of their tolerogenic phenotype, displayed by features such as semimature phenotype, low surface expression of stimulatory molecules to prime T cells, as well as the elevated expression of inhibitory markers. DCs may be obtained and propagated easily in optimal amounts from peripheral blood or bone marrow precursors, such as monocytes or hematopoietic stem cells, respectively; therefore, various protocols have been established for tolerogenic (tol)DCs manufacturing for therapeutic research in the treatment of T1D. In this review, we address the current advances in the use of tolDCs for T1D therapy, encompassing protocols for their manufacturing, the data obtained from preclinical studies carried out, and the status of clinical research evaluating the safety, feasibility, and effectiveness of tolDCs., Competing Interests: Conflict-of-interest statement: The authors have declared having no conflicts of interest., (©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
21. T Cells Subsets in the Immunopathology and Treatment of Sjogren's Syndrome.
- Author
-
Ríos-Ríos WJ, Sosa-Luis SA, and Torres-Aguilar H
- Subjects
- Animals, Cytokines genetics, Cytokines immunology, Humans, Sjogren's Syndrome genetics, Immunotherapy, Sjogren's Syndrome immunology, Sjogren's Syndrome therapy, T-Lymphocyte Subsets immunology
- Abstract
Sjogren´s syndrome (SS) is an autoimmune disease whose pathogenesis is characterized by an exacerbated T cell infiltration in exocrine glands, markedly associated to the inflammatory and detrimental features as well as the disease progression. Several helper T cell subsets sequentially converge at different stages of the ailment, becoming involved in specific pathologic roles. Initially, their activated phenotype endows them with high migratory properties and increased pro-inflammatory cytokine secretion in target tissues. Later, the accumulation of immunomodulatory T cells-derived factors, such as IL-17, IFN-γ, or IL-21, preserve the inflammatory environment. These effects favor strong B cell activation, instigating an extrafollicular antibody response in ectopic lymphoid structures mediated by T follicular helper cells (Tfh) and leading to disease progression. Additionally, the memory effector phenotype of CD8+ T cells present in SS patients suggests that the presence of auto-antigen restricted CD8+ T cells might trigger time-dependent and specific immune responses. Regarding the protective roles of traditional regulatory T cells (Treg), uncertain evidence shows decrease or invariable numbers of circulating and infiltrating cells. Nevertheless, an emerging Treg subset named follicular regulatory T cells (Tfr) seems to play a critical protective role owing to their deficiency that enhances SS development. In this review, the authors summarize the current knowledge of T cells subsets contribution to the SS immunopathology, focusing on the cellular and biomolecular properties allowing them to infiltrate and to harm target tissues, and that simultaneously make them key therapeutic targets for SS treatment., Competing Interests: The authors declare no conflict of interest.
- Published
- 2020
- Full Text
- View/download PDF
22. Silent red blood cell autoantibodies: Are they naturally occurring or an effect of tolerance loss for a subsequent autoimmune process?
- Author
-
Torres-Aguilar H, Sosa-Luis SA, Ríos-Ríos WJ, Romero-Tlalolini MLÁ, and Aguilar-Ruiz SR
- Subjects
- Anemia, Hemolytic, Autoimmune diagnosis, Autoantibodies blood, Autoantigens immunology, Autoimmune Diseases etiology, Autoimmunity, Disease Susceptibility, Humans, Immune Tolerance, Anemia, Hemolytic, Autoimmune blood, Anemia, Hemolytic, Autoimmune etiology, Autoantibodies immunology, Erythrocytes immunology
- Abstract
Unexpected anti-red blood cell (RBC) alloantibodies are routinely investigated in immunohematology and blood banking since their existence in pregnant women may induce haemolytic disease of the foetus and newborn, and their presence in donors may induce haemolytic transfusion reactions or hyperacute rejection in solid organ transplantation. Unexpected anti-RBC alloantibodies may target antigens of the most blood types excluding the expected antibodies targeting the ABO antigens. Their incidence in humans was originally linked to alloimmunization events such as blood transfusions, transplants, or pregnancies. But later, many findings revealed their existence in pathogenic processes such as malignancies, infections, and autoimmune diseases; and usually (but not always) associated to autoimmune haemolytic anaemia (AIHA). Nevertheless, unexpected anti-RBC autoantibodies are also occasionally found in healthy individuals in the absence of AIHA and with no history of alloimmunization or the associated pathologic processes. Hence, they are generally known as non-clinically significant, are excluded for typification and called "silent red blood cell autoantibodies (SRBCAA)". This review highlights evidence related to genetic predisposition, molecular mimicry, immune dysregulation, and immune tolerance loss surrounding the existence of anti-RBC antibodies, describing the presence of SRBCAA as possible early witnesses of the development of autoimmune diseases.
- Published
- 2020
- Full Text
- View/download PDF
23. Presence of HPV DNA in extracellular vesicles from HeLa cells and cervical samples.
- Author
-
Mata-Rocha M, Rodríguez-Hernández RM, Chávez-Olmos P, Garrido E, Robles-Vázquez C, Aguilar-Ruiz S, Torres-Aguilar H, González-Torres C, Gaytan-Cervantes J, Mejía-Aranguré JM, and Romero-Tlalolini MLA
- Subjects
- Female, HeLa Cells, Humans, Oncogene Proteins, Viral genetics, Cervix Uteri virology, DNA, Viral isolation & purification, Extracellular Vesicles virology, Papillomavirus Infections diagnosis
- Abstract
Introduction: The main cause of cervical cancer is an infection of keratinocytes in the basal layer of the stratified epithelium of the cervix by human papillomavirus (HPV). Other than in cervical samples, HPV DNA has been found in serum and other fluids but its origin is unclear. Extracellular vesicles (EV) could be a conveyance of viral DNA given their emerging role in cellular communication. The content of EV derived from cervical cells has not been properly explored and it is not known whether or not they contain HPV DNA., Methods: We evaluated the DNA content of exosomes purified from cultures of HeLa cells by Next Generation Sequencing (NGS) and confirmed its presence by PCR. The presence of HPV DNA was also evaluated by PCR and NGS in EV from HPV-positive cervical samples without apparent lesion or with LSIL., Results: We detected the integrated form of viral-DNA in exosomes from HeLa cells by NGS and confirmed its presence by PCR. The search for HPV sequences in EV obtained from cervical exudate samples without apparent lesion or with LSIL, where we expected to find the viral genome as an episome, indicated that HPV DNA, including the E6 and E7 oncogenes, is present in these EV., Conclusion: HPV DNA, including the viral oncogenes E6/E7, is found in exosomes regardless of the integration status of the virus in the infected cell., (Copyright © 2019 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
24. Prevalence and risk factors to Demodex folliculorum infection in eyelash follicles from a university population of Mexico.
- Author
-
Vargas-Arzola J, Segura-Salvador A, Torres-Aguilar H, Urbina-Mata M, Aguilar-Ruiz S, Díaz-Chiguer DL, Márquez-Navarro A, Morales-Reyes L, Alvarado-Vásquez N, and Nogueda-Torres B
- Subjects
- Adolescent, Adult, Animals, Body Weight, Contact Lenses adverse effects, Cosmetics adverse effects, Eyeglasses adverse effects, Female, Humans, Male, Mexico epidemiology, Middle Aged, Prevalence, Prospective Studies, Risk Factors, Young Adult, Eyelashes parasitology, Hair Follicle parasitology, Mite Infestations epidemiology, Mites
- Abstract
Demodex folliculorum shows a high occurrence in the general population, however, its pathologic relevance is still controversial. In this prospective study, we evaluated the prevalence of D. folliculorum on eyelashes from 8,033 subjects of a university population (including 7,782 students, and 251 academics). Additional information on some risk factors to infection by the mites was evaluated, as well. A prevalence of 1.47% was found, where 118 individuals were positive for D. folliculorum; and, among them, 63 (53.4%) were women and 55 (46.6%) were men. Results showed a negative correlation with the age (r = -0.45), the highest prevalence was found in individuals between 19 and 22 years of age (2.1%, 84 patients). The number of D. folliculorum mites did not differ between the right and left eye; however, the use of cosmetics or facial cream, contact lens, hair removers, were factors present in patients infected with D. folliculorum. Although Demodex prevalence did not increase in line with weight, we found significantly higher prevalence in the 51-60 kg and 71-80 kg weight groups, and a particularly high prevalence in the over 81 kg weight group (2.6%). In conclusion, it was observed that the main population positive to infection consisted of young adults; this is in contrast with the international evidence reporting a high rate of infection in older adults. Besides, our results suggest that items of daily use such as cosmetics, facial cream, eyeliner, glasses, or contact lenses may be some of the main culprits of the infection by D. folliculorum.
- Published
- 2020
- Full Text
- View/download PDF
25. Human platelets and megakaryocytes express defensin alpha 1.
- Author
-
Valle-Jiménez X, Ramírez-Cosmes A, Aquino-Domínguez AS, Sánchez-Peña F, Bustos-Arriaga J, Romero-Tlalolini MLÁ, Torres-Aguilar H, Serafín-López J, and Aguilar Ruíz SR
- Subjects
- Anti-Infective Agents pharmacology, Biomarkers, Blood Platelets drug effects, Cell Line, Cytoplasmic Granules metabolism, Fluorescent Antibody Technique, Humans, Immunophenotyping, Megakaryocytes drug effects, Peptides genetics, Platelet Activation genetics, RNA, Messenger genetics, RNA, Messenger metabolism, Recombinant Proteins, Thrombopoietin pharmacology, Blood Platelets metabolism, Gene Expression Regulation, Megakaryocytes metabolism, alpha-Defensins genetics
- Abstract
Platelets are anucleate cells that have a role in several innate immune functions, including the secretion of proteins with antimicrobial activity. Several studies have demonstrated the ability of platelets to secrete thrombin-induced platelet microbicidal proteins and antimicrobial peptides, like hBD-1. However, the expression and secretion of defensins of the alpha family by platelets have not been fully elucidated. The aim of this study was to characterize the expression of defensin alpha 1 (DEFA1) in human platelets and megakaryocytes. Our data indicate that DEFA1 mRNA and protein are present in peripheral blood platelets and in the megakaryoblastic leukemia cell line (MEG-01). DEFA1 co-localize with α-granules of platelets and MEG-01 cells, and was also detected in cytoplasm of MEG-01 cells. The assay of our in vitro model of platelet-like particles (PLPs) revealed that MEG-01 cells could transfer DEFA1 mRNA to their differentiated PLPs. Furthermore, platelets secreted DEFA1 into the culture medium when activated with thrombin, adenosine diphosphate, and lipopolysaccharide; meanwhile, MEG-01 cells secreted DEFA1 when activated with thrombopoietin. Platelet's secreted DEFA1 can rebind to platelet's surface and have antibacterial activity against the gram-negative bacteria Escherichia coli . In summary, our data indicate that both, human platelets and megakaryocytes, can express and secrete DEFA1. These results suggest a new role of platelets and megakaryocytes in the innate immune response.
- Published
- 2020
- Full Text
- View/download PDF
26. Infections as triggers of flares in systemic autoimmune diseases: novel innate immunity mechanisms.
- Author
-
Torres-Aguilar H, Sosa-Luis SA, and Aguilar-Ruiz SR
- Subjects
- Autoimmune Diseases etiology, Autoimmunity, Humans, Infections complications, Adaptive Immunity immunology, Autoimmune Diseases immunology, Immunity, Innate, Infections immunology
- Abstract
Purpose of Review: The innate immune response (IIR) has to be immediate facing pathogens, and effective to induce a long-lasting adaptive immunity and immune memory. In genetically susceptible individuals, beyond a first defense, a chronically activated by infections IIR may represent a trigger for the onset or flares in systemic autoimmune diseases. This article reviews the recent scientific literature in this regard and highlights the key issues needing investigation., Recent Findings: Thanks to its high specificity mediated by pattern recognition receptors, the IIR is not called unspecific anymore. The discovery of these increasingly accurate recognizing molecular mechanisms has also evidenced their involvement in breaking self-immune tolerance and to maintain chronic inflammation in autoimmune responses. Neutrophil extracellular traps (NETS) as the main source of antinuclear antibodies; the 'neutrophils-pDC activation loop' theory; and the Th1/Th2/Th17 misbalances induced by microbial products because of chronically activated innate immune cells, are some of the recent uncovered IIR origins involved in infectious-induced systemic autoimmune diseases., Summary: A deeper understanding of the genetic predisposition and the pathogen-derived factors responsible to exacerbate the IIR might potentially provide therapeutic targets to counteract flares in systemic autoimmune diseases. VIDEO ABSTRACT.
- Published
- 2019
- Full Text
- View/download PDF
27. Evaluation of the Interference of Lipemia and Hemolysis in the Detection Limit of Anti-HIV-1 Antibodies.
- Author
-
Mendoza-Benitez PS, Aguilar-Ruiz SR, Romero-Tlalolini MD, and Torres-Aguilar H
- Subjects
- AIDS Serodiagnosis methods, HIV Antibodies blood, HIV Infections blood, HIV Infections virology, HIV Seropositivity blood, HIV Seropositivity virology, HIV-1 physiology, Hemoglobins immunology, Hemoglobins metabolism, Hemolysis immunology, Humans, Hyperlipidemias blood, Hyperlipidemias immunology, Limit of Detection, Lipids blood, Lipids immunology, Sensitivity and Specificity, HIV Antibodies immunology, HIV Infections diagnosis, HIV Seropositivity diagnosis, HIV-1 immunology
- Abstract
Background: The instructions of manufacturers of methodologies for anti-HIV-1/2 antibodies screening tests re-commend avoiding analyzing blood samples with hemolysis or lipemia, but they do not mention references about scientific studies evaluating their interference. The increased need for an opportune detection of HIV infection to avoid its spread has led to public health institutions including routine HIV screening even in internal medicine and emergency rooms. Nevertheless, these blood samples are usually associated with the presence of lipemia and/ or hemolysis, leaving doubt for probable misinterpretations. This fact highlights the need for applying verification techniques, established under the internal methodological conditions of each laboratory, in order to increase the coverage of HIV screening and to ensure the reliability of their results., Methods: Following the ethics committee approval and patient's informed consent, a confirmed anti-HIV-1 positive human serum (undetectable viral load and p24 antigen, and stable total lymphocytes > 30%) was obtained. This work describes techniques for the semiquantitative analysis of anti-HIV antibodies of three commercial HIV-screening methodologies (immunochromatography, enzyme-immunoassay and chemiluminescence) and to deter-mine the detection limit of these screening tests, as well as evaluating the maximum concentration of total lipids and of free hemoglobin that do not interfere in the detection limits., Results: The highest analyzed concentration of total lipid (870 mg/dL) did not interfere with the detection limits of anti-HIV-1 antibodies in any of the evaluated methodologies. Free hemoglobin presented interference at different concentrations depending on the methodology: immunochromatography (0.57 g/dL)), enzyme-immunoassay (8.6 g/dL), and chemiluminescence (11.5 g/dL))., Conclusions: Concentrations of lipemia above postprandial levels or hemolysis induced by experimental manipulation might not interfere with HIV-serological screening. Determining the maximum permissible limits of lipemia and hemolysis by each manufacturer or laboratory based on an internal evaluation of their serological methodology would increase the reliability of HIV-diagnosis in internal medicine and emergency rooms and in patients with dyslipidemia or physiological hemolysis.
- Published
- 2019
- Full Text
- View/download PDF
28. Prolactin has a pathogenic role in systemic lupus erythematosus.
- Author
-
Jara LJ, Medina G, Saavedra MA, Vera-Lastra O, Torres-Aguilar H, Navarro C, Vazquez Del Mercado M, and Espinoza LR
- Subjects
- Adaptive Immunity, Animals, Antibodies, Antinuclear blood, Disease Models, Animal, Female, Humans, Hyperprolactinemia drug therapy, Hyperprolactinemia epidemiology, Immunity, Innate, Immunocompetence, Lupus Erythematosus, Systemic drug therapy, Lupus Erythematosus, Systemic epidemiology, Lupus Nephritis drug therapy, Mice, Pregnancy, Pregnancy Complications drug therapy, Pregnancy Complications epidemiology, Prolactin immunology, Receptors, Prolactin metabolism, Bromocriptine therapeutic use, Dopamine Agonists therapeutic use, Hyperprolactinemia immunology, Lupus Erythematosus, Systemic immunology, Lupus Nephritis immunology, Pregnancy Complications immunology, Prolactin metabolism
- Abstract
Prolactin, a 23-kDa peptide hormone, is produced by the anterior pituitary gland and extrapituitary sites including the immune cells. Prolactin (PRL) participates in innate and adaptive immune response. PRL stimulates the immune cells by binding to receptor (PRL-R). Binding of PRL to its receptor activates the Janus kinase-signal transducer (JAK-STAT). Activation of these cascades results in endpoints such as immunoestimulator and immunosupressor action. Prolactin belongs to the network of immune-neuroendocrine interaction. Hyperprolactinemia has been found in patients with systemic lupus erythematosus (SLE), and new evidence has confirmed a significant correlation between serum PRL levels and disease activity. PRL participates in activation of SLE during pregnancy and in pathogenesis of lupus nephritis, neuropsychiatric, serosal, hematologic, articular, and cutaneous involvement. Hyperprolactinemia was associated with increase IgG concentrations, anti-DNA antibodies, immune complex, glomerulonephritis, and accelerated mortality in murine lupus. Bromocriptine, a dopamine analog that suppresses PRL secretion, was associated with decreased lupus activity, prolonged lifespan, and restoration of immune competence in experimental model. In clinical trials, bromocriptine and derivative drugs showed beneficial therapeutic effect in treating human lupus, including pregnancy. Taken together, clinical and experimental results leave little doubt that PRL indeed contributes to the pathogenesis and clinical expression of SLE.
- Published
- 2017
- Full Text
- View/download PDF
29. Irregular antibodies in no hemolytic autoimmune diseases are able to induce erythrophagocytosis.
- Author
-
López-Díaz PE, Ruiz-Olivera MDR, Hernández-Osorio LA, Vargas-Arzola J, Valle-Jiménez X, Aguilar-Ruiz SR, and Torres-Aguilar H
- Subjects
- Adult, Aged, Aged, 80 and over, Antigens immunology, Autoantibodies blood, Complement System Proteins, Female, Hemolysis, Humans, Middle Aged, Phagocytosis, Autoantibodies immunology, Autoimmune Diseases blood, Autoimmune Diseases immunology, Erythrocytes immunology
- Abstract
Irregular antibodies are produced by alloimmunization because of pregnancies or blood transfusions. They are called "irregular" due to target erythrocyte antigens from "rare blood systems," those different from the ABO system. Irregular antibodies have been widely investigated in immunohematology since their presence in blood donors may lead to difficulties in blood typing and in blood cross-matching, or to induce hemolytic transfusion reactions. Nevertheless, their incidence and participation in the physiopathology of autoimmune diseases have not been thoroughly studied. In this work, we analyzed the presence and pro-hemolytic capabilities of irregular antibodies in patients with different autoimmune diseases lacking signs of hemolytic anemia, in comparison with healthy multiparous women. Five of 141 autoimmune patients (3.5 %) and two of 77 multiparous women (2.6 %) were positive. Although frequency was relatively low and similar in both populations, the targeted antigens were Kell (k, Kp
b , Jsb ) and Luth (Lub ) in multiparous women, and the same plus Duffy (Fya ), Kidd (Jka ) and MNS (M, s) in autoimmune patients. Irregular antibodies from autoimmune patients did not induce complement-mediated hemolysis (intravascular), but they were able to induce macrophages-mediated phagocytosis (extravascular hemolysis) in vitro. It is the first approach exploring the presence of irregular antibodies associated with the loss of immune tolerance and demonstrating their hemolytic potential in autoimmune patients without hemolytic manifestations. The presence of irregular antibodies targeted to Duffy (Fya), Kidd (Jka) and MNS (M, s) antigens only in autoimmune patients suggests a loss of immune tolerance to these erythrocyte antigens.- Published
- 2017
- Full Text
- View/download PDF
30. Human CD4(+) effector T lymphocytes generated upon TCR engagement with self-peptides respond defectively to IL-7 in their transition to memory cells.
- Author
-
González-Pérez G, Segovia NC, Rivas-Carvalho A, Reyes DP, Torres-Aguilar H, Aguilar-Ruiz SR, Irles C, Soldevila G, and Sánchez-Torres C
- Subjects
- CD4-Positive T-Lymphocytes drug effects, Cell Proliferation drug effects, Cell Separation, Cell Survival drug effects, Cell Survival immunology, Humans, Immunophenotyping, Lymphocyte Activation drug effects, Signal Transduction drug effects, Signal Transduction immunology, CD4-Positive T-Lymphocytes cytology, CD4-Positive T-Lymphocytes immunology, Immunologic Memory drug effects, Interleukin-7 pharmacology, Peptides metabolism, Receptors, Antigen, T-Cell metabolism
- Abstract
The peripheral repertoire of CD4(+) T lymphocytes contains autoreactive cells that remain tolerant through several mechanisms. However, nonspecific CD4(+) T cells can be activated in physiological conditions as in the course of an ongoing immune response, and their outcome is not yet fully understood. Here, we investigate the fate of human naive CD4(+) lymphocytes activated by dendritic cells (DCs) presenting endogenous self-peptides in comparison with lymphocytes involved in alloresponses. We generated memory cells (Tmem) from primary effectors activated with mature autologous DCs plus interleukin (IL)-2 (Tmauto), simulating the circumstances of an active immune response, or allogeneic DCs (Tmallo). Tmem were generated from effector cells that were rested in the absence of antigenic stimuli, with or without IL-7. Tmem were less activated than effectors (demonstrated by CD25 downregulation) particularly with IL-7, suggesting that this cytokine may favour the transition to quiescence. Tmauto and Tmallo showed an effector memory phenotype, and responded similarly to polyclonal and antigen-specific stimuli. Biochemically, IL-7-treated Tmallo were closely related to conventional memory lymphocytes based on Erk-1/2 activation, whereas Tmauto were more similar to effectors. Autologous effectors exhibited lower responses to IL-7 than allogeneic cells, which were reflected in their reduced proliferation and higher cell death. This was not related to IL-7 receptor expression but rather to signalling deficiencies, according to STAT5 activation These results suggest that ineffective responses to IL-7 could impair the transition to memory cells of naive CD4(+) T lymphocytes recognizing self-peptides in the setting of strong costimulation.
- Published
- 2013
- Full Text
- View/download PDF
31. Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4⁺ T cell response to β2GPI.
- Author
-
Torres-Aguilar H, Blank M, Kivity S, Misgav M, Luboshitz J, Pierangeli SS, and Shoenfeld Y
- Subjects
- Adult, Aged, Cell Differentiation immunology, Cell Proliferation, Cells, Cultured, Coculture Techniques, Cytokines biosynthesis, Female, Humans, Immune Tolerance immunology, Immunologic Memory immunology, Immunophenotyping, Lymphocyte Activation immunology, Male, Middle Aged, Antiphospholipid Syndrome immunology, CD4-Positive T-Lymphocytes immunology, Dendritic Cells immunology, beta 2-Glycoprotein I immunology
- Abstract
Objectives: The importance of β(2)-glycoprotein I (β(2)GPI)-specific CD4(+) T cells in the development of pathogenic processes in patients with antiphospholipid syndrome (APS) and APS mouse models is well established. Therefore, our objective is to manipulate the β2GPI specific CD4(+) T cells using tolerogenic dendritic cells (tDCs) to induce tolerance. We aim to evaluate the capability of tDCs to induce antigen-specific tolerance in effector/memory T cells from patients with APS and to elucidate the involved mechanism., Methods: DCs and tDCs were produced from patients with APS peripheral-blood-monocytes, using specific cytokines. β(2)GPI-specific tolerance induction was investigated by coculturing control DC (cDC) or tDC, β(2)GPI-loaded, with autologous effector/memory T cells, evaluating the proliferative response, phenotype, cytokines secretion, viability and regulatory T cells., Results: Human monocyte-derived DCs treated with interleukin (IL)-10 and transforming growth factor β-1 (10/TGF-DC) induced β(2)GPI-specific-unresponsiveness in effector/memory CD4(+) T cells (46.5% ± 26.0 less proliferation) in 16 of 20 analysed patients with APS, without affecting the proliferative response to an unrelated candidin. In five analysed patients, 10/TGF-DC-stimulated T cells acquired an IL-2(low)interferon γ(low)IL-10(high) cytokine profile, with just a propensity to express higher numbers of Foxp3(+)CTLA-4(+) cells, but with an evident suppressive ability. In four of 10 analysed patients, 10/TGF-DC-stimulated T cell hyporesponsiveness could not be reverted and showed higher percentages of late apoptosis, p<0.02., Conclusions: The inherent tolerance induction resistance of activated T cells present during the development of autoimmune diseases has delayed the application of tDC as an alternative therapy. This study highlights the 10/TGF-DC feasibility to induce antigen-specific unresponsiveness in autoreactive T cells generated in patients with APS by inducing apoptosis or T cells with regulatory abilities.
- Published
- 2012
- Full Text
- View/download PDF
32. Human CD16+ and CD16- monocyte subsets display unique effector properties in inflammatory conditions in vivo.
- Author
-
Aguilar-Ruiz SR, Torres-Aguilar H, González-Domínguez É, Narváez J, González-Pérez G, Vargas-Ayala G, Meraz-Ríos MA, García-Zepeda EA, and Sánchez-Torres C
- Subjects
- Adoptive Transfer, Animals, GPI-Linked Proteins biosynthesis, GPI-Linked Proteins metabolism, Humans, Immunity, Innate, Inflammation immunology, Inflammation metabolism, Inflammation pathology, Lipopolysaccharides pharmacology, Mice, Mice, SCID, Monocytes transplantation, Peritonitis immunology, Peritonitis metabolism, Peritonitis pathology, Receptors, IgG metabolism, Zymosan pharmacology, Inflammation Mediators physiology, Monocytes immunology, Monocytes pathology, Receptors, IgG biosynthesis
- Abstract
Two major subsets of human Mo are identified based on CD14 and CD16 expression: the classical CD16(-) Mo and the minor CD14(+)CD16(+) Mo. In vitro studies suggested distinct function and differentiation potential for each cell population. However, the in vivo relevance of these findings remains unclear. To evaluate the development and function of human Mo in an in vivo model, we transferred both Mo subpopulations into the peritoneum of immunocompromised mice in homeostatic or inflammatory conditions. Inflammation was induced with soluble LPS or particulate zymosan. CD16(+) were more phagocytic and produced higher amounts of TNF and IL-6 than CD16(-) Mo early after transfer with zymosan. They also produced higher levels of β2-defensin in any condition evaluated, which could represent a new marker for this subpopulation. In contrast, differentiating CD16(-) Mo (24 h after transfer) acquired greater APC capacity in LPS-induced peritonitis, whereas none of the Mo subsets attained this ability with zymosan. CX(3)CL1 supported the survival of both Mo subsets in vivo. Similar Mo subpopulations were present in human peritonitis. These results support the idea of specialized roles of the Mo subset, where CD16(+) might act in an immediate innate immune response, whereas CD16(-) could have a major role as APCs.
- Published
- 2011
- Full Text
- View/download PDF
33. Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity.
- Author
-
Torres-Aguilar H, Blank M, Jara LJ, and Shoenfeld Y
- Subjects
- Humans, Autoimmune Diseases immunology, Autoimmune Diseases prevention & control, Dendritic Cells immunology, Immune Tolerance
- Abstract
The immune system has evolved to coordinate responses against numerous invading pathogens and simultaneously remain silent facing self-antigens and those derived from commensal organisms. But, if both processes are not maintained in strict balance, a potential threat can emerge due to the risk of chronic inflammation and/or autoimmunity development. Therefore, there is a negative immune regulation where tolerogenic dendritic cells (tDCs) participate actively. Under steady-state conditions, tDC are notably involved in the elimination of autoreactive T cells at the thymus, and in the control of T cells specific to self and harmless antigens in the periphery. But in the presence of foreign antigens in an inflammatory milieu, dendritic cells (DCs) mature and induce T cells activation and their migration to B cell areas to assist in antibody production. Additionally, there are other factors such as infections, anti tumoral immune responses, trauma-mediated disruption, etc. that may induce alterations in the balance between tolerogenic and immunogenic functions of DCs and instigate the development of autoimmune diseases (ADs). Therefore, in recent years, DCs have emerged as therapeutic targets to control of ADs. Diverse strategies in vitro and/or in animal models of ADs have explored the tolerogenic functions of DCs and demonstrated their feasibility to prevent or control an autoimmune process, but still leaving a void in their application in clinical assays. The purpose of this paper is to give a general overview of the current literature on the significance of tDCs in tolerance maintenance to self and innocuous antigens, the most relevant alterations involved in the pathophysiology of ADs, the cellular and molecular mechanisms involved in their tolerogenic function and the current strategies used to exploit their tolerogenic potential., (Published by Elsevier B.V.)
- Published
- 2010
- Full Text
- View/download PDF
34. IL-10/TGF-beta-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector/memory T cells from type 1 diabetic individuals.
- Author
-
Torres-Aguilar H, Sánchez-Torres C, Jara LJ, Blank M, and Shoenfeld Y
- Subjects
- Adult, Antigen Presentation drug effects, Antigens, Differentiation metabolism, CD4-Positive T-Lymphocytes immunology, CD4-Positive T-Lymphocytes pathology, Cell Differentiation drug effects, Dendritic Cells drug effects, Dendritic Cells immunology, Dendritic Cells pathology, Diabetes Mellitus, Type 1 immunology, Female, Humans, Immune Tolerance, Immunologic Memory, Insulin metabolism, Interleukin-10 pharmacology, Lymphocyte Activation drug effects, Male, T-Lymphocyte Subsets immunology, T-Lymphocyte Subsets pathology, Transforming Growth Factor beta pharmacology, CD4-Positive T-Lymphocytes metabolism, Dendritic Cells metabolism, Diabetes Mellitus, Type 1 therapy, Immunotherapy, T-Lymphocyte Subsets metabolism
- Abstract
Introduction: Diabetogenic autoreactive T cells with effector/memory characteristics are described in type 1 diabetes patients (T1D). Alternatively activated dendritic cells (aaDCs) have been regarded as promising tools for clinical application in autoimmune diseases (ADs), although their ability to induce antigen-specific tolerance in T cells derived from ADs has yet to be determined., Methods: Monocyte-derived dendritic cells (DCs) were produced utilizing GM-CSF and IL-4, and aaDCs by adding IL-10 and TGF-beta (10/TGF-DC) during differentiation. Both cell groups were insulin-loaded, maturated with lipopolysaccharide, and cocultured with autologous effector/memory T cells derived from T1D individuals, in order to evaluate the induction of insulin-specific tolerance., Results and Discussion: In five of eight T1D patients analyzed in vitro, 10/TGF-DC were able to induce insulin-specific tolerance in effector/memory CD4+ T cells (50.4% +/- 13.2 less proliferation), without affecting the proliferative response to an unrelated antigen (candidin). Tolerance induction was dependent on the current activation state of CD4+ T cells in each patient. 10/TGF-DC-stimulated T cells acquired an IL-2(low)IFN-gamma(low)IL-10(high) cytokine profile, and their hyporesponsiveness could be reverted upon exposure to IL-2. This study shows a perspective about the in vitro ability of monocyte-derived 10/TGF-DC to induce antigen-specific tolerance in effector/memory T cells generated during the course of an autoimmune disease.
- Published
- 2010
- Full Text
- View/download PDF
35. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells.
- Author
-
Torres-Aguilar H, Aguilar-Ruiz SR, González-Pérez G, Munguía R, Bajaña S, Meraz-Ríos MA, and Sánchez-Torres C
- Subjects
- Antigens, Differentiation, B-Lymphocyte physiology, CD4-Positive T-Lymphocytes metabolism, Cells, Cultured, Clonal Anergy immunology, Dendritic Cells classification, Dinoprostone physiology, Histocompatibility Antigens Class II physiology, Humans, Immunosuppressive Agents pharmacology, Interleukin-10 physiology, Macrophages classification, Macrophages immunology, Macrophages metabolism, T-Lymphocytes, Regulatory immunology, T-Lymphocytes, Regulatory metabolism, Thrombospondin 1 physiology, CD4-Positive T-Lymphocytes immunology, Cell Differentiation immunology, Cytokines physiology, Dendritic Cells immunology, Dendritic Cells metabolism, Epitopes, T-Lymphocyte immunology, Immune Tolerance, Immunologic Memory
- Abstract
Dendritic cells (DCs) are professional APCs involved in the initiation of both immunity and immunological tolerance. In autoimmune diseases or graft rejections, most reactive lymphocytes are effector/memory cells. It is believed that memory T cells are more resistant to tolerance induction than naive lymphocytes; however, studies on mechanisms for their efficient tolerization are still scarce. In this study, we generated human monocyte-derived DCs by culture with GM-CSF and IL-4 (control DCs), as well as tolerogenic DCs (tDCs) by adding IL-10, IL-10/TGF-beta1, or IL-10/IL-6. Cells were maturated with TNF-alpha/PGE(2). Compared with control DCs, tDCs had similar expression of HLA-DR, CD80, and CD86, lower expression of CD40, higher levels of macrophage markers, enhanced endocytic ability, increased secretion of IL-6, IL-10 (only tDCs generated with IL-10 and tDCs generated with IL-10/IL-6), and PGE(2), and lower secretion of IL-12 and IL-23. In vitro, tDCs had the capacity to induce anergy in tetanus toxoid-specific memory CD4(+) T cells, whereas the proliferative response to an unrelated Ag was intact. Anergy could be reverted upon exposure to IL-2. tDC-primed T cells have low suppressive ability. Nevertheless, the generation of both anergic and regulatory T cells was more efficient with tDCs generated with IL-10/TGF-beta1. Microarray-based gene expression profiling reflected modulated expression of several transcripts in tDCs. Surface CLIP-HLA-DR complexes and intracellular thrombospondin-1 were increased in the three tDCs. CD39 was highly expressed only in tDC-TGF, which correlated with increased adenosine production. We propose that these molecules, together with IL-10 and prostanoids, are key factors to induce Ag-specific tolerance in memory T cells.
- Published
- 2010
- Full Text
- View/download PDF
36. Differential CD4(+) T-cell memory responses induced by two subsets of human monocyte-derived dendritic cells.
- Author
-
Bajaña S, Herrera-González N, Narváez J, Torres-Aguilar H, Rivas-Carvalho A, Aguilar SR, and Sánchez-Torres C
- Subjects
- Antigen Presentation immunology, Cell Proliferation, Cells, Cultured, Dose-Response Relationship, Immunologic, Humans, Immunophenotyping, Interferon-gamma biosynthesis, Lymphocyte Activation immunology, Tetanus Toxoid immunology, Tuberculin immunology, CD4-Positive T-Lymphocytes immunology, Dendritic Cells immunology, Immunologic Memory
- Abstract
Dendritic cells (DC) are powerful inducers of primary T-cell responses, but their role in secondary responses has not been extensively analysed. Here, we address the role of two DC subsets derived from human CD16(+) (16(+) mDC) or CD16(-) (16(-) mDC) monocytes on the reactivation of memory responses. CD4(+) CD45RA(-) memory T cells were obtained from adult blood donors, and central (T(CM)) and effector (T(EM)) memory T cells were isolated by fluorescence-activated cell sorting with anti-CCR7 antibodies. The 16(+) mDC and 16(-) mDC were cocultured with autologous lymphocytes, either unpulsed or loaded with purified protein derivatives of Mycobacterium tuberculosis (PPD) or tetanus toxoid (TT), and were analysed for up to 8 days. Over a range of doses, 16(+) mDC drove stronger T-cell proliferative responses against both antigens. Overall, antigen-specific memory cells tended to acquire a phenotype of T(EM) at later time-points in the culture, whereas cells that had completed fewer cycles of division were similar to T(CM). The 16(+) mDC induced higher rates of proliferation on both T(CM) and T(EM) lymphocytes than 16(-) mDC. This phenomenon was not related to the ability of both DC to induce CD25 expression on T cells, to lower secretion of interleukin-2, or to raise production of interleukin-10 during T-cell/16(-) mDC cocultures. The induction of T(CM) effector capacity in terms of interferon-gamma production was faster and more pronounced with 16(+) mDC, whereas both DC had similar abilities with T(EM). In conclusion, these data might reveal new potentials in vaccination protocols with 16(+) mDC aimed at inducing strong responses on central memory T cells.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.